Clinical

Dataset Information

0

In the second or higher standard chemotherapy failure in patients with advanced colorectal cancer using mesylate apatinib tablets multicenter, open, single arm and exploratory research

ABSTRACT: Interventions: treatment group:Restricted entry Primary outcome(s): PFS Study Design: Case series

DISEASE(S): Colon Cancer

PROVIDER: 2670767 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Json Xml

Similar Datasets

Unknown A single-arm, prospective study of apatinib mesylate plus pemetrexed in patients of advanced non-squamous non-small cell lung cancer after failure of previous chemotherapy.
| S-EPMC8848392 | biostudies-literature
Clinical Apatinib Mesylate Tablets of joint mFOLFOX6 neoadjuant chemotherapy in locally advanced colorectal cancer clinical research
| 2670768 | ecrin-mdr-crc
Unknown Apatinib combined with paclitaxel-based chemotherapy in patients with taxane-resistant advanced gastric cancer: a single-arm exploratory study.
| S-EPMC7607108 | biostudies-literature
Unknown Neoadjuvant camrelizumab plus chemotherapy or apatinib for resectable stage IIA-IIIA NSCLC: a multicenter, two-arm, phase II exploratory trial.
| S-EPMC12275288 | biostudies-literature
Unknown Camrelizumab and apatinib in Chinese patients with locally advanced or metastatic radioiodine-refractory differentiated thyroid cancer: an exploratory open-label, single-arm trial.
| S-EPMC12828957 | biostudies-literature
Unknown Hepatic artery infusion chemotherapy combined with camrelizumab and apatinib as conversion therapy for patients with unresectable hepatocellular carcinoma: a single-arm exploratory trial.
| S-EPMC12056981 | biostudies-literature
Unknown Structure based release kinetics analysis of doxazosin mesylate sustained-release tablets using micro-computed tomography.
| S-EPMC11617939 | biostudies-literature
Transcriptomics Hand and Arm Dysfunction is Prevalent Following Hemodialysis Access Placement and Associated with Higher Rate of Access Failure
2026-01-01 | GSE287576 | GEO
Unknown Apatinib for patients with metastatic biliary tract carcinoma refractory to standard chemotherapy: results from an investigator-initiated, open-label, single-arm, exploratory phase II study.
| S-EPMC8411636 | biostudies-literature
Unknown Apatinib Mesylate in the treatment of advanced progressed lung adenocarcinoma patients with EGFR-TKI resistance -A Multicenter Randomized Trial.
| S-EPMC6768876 | biostudies-literature